Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease

Clin J Am Soc Nephrol. 2010 Oct;5(10):1780-6. doi: 10.2215/CJN.02560310. Epub 2010 Jun 24.

Abstract

Background and objectives: Cardiovascular disease in chronic kidney disease (CKD) is explained in part by traditional cardiovascular risk factors; by uremia-specific factors; and by abnormalities of mineral metabolism, factors involved in its regulation, and in the vascular calcification process.

Design, setting, participants, & measurements: In an unselected population of 177 patients with calculated GFR (eGFR) between 90 and 30 ml/min per 1.73 m(2), the link between the mineral metabolism abnormalities (calcium, phosphorus, calcium-phosphorus product), regulatory factors (parathyroid hormone [PTH], intact PTH [iPTH], vitamin D, fibroblast growth factor 23 [FGF 23], and fetuin A), and the severity of coronary artery disease (CAD) assessed by coronary angiography were evaluated in three subgroups defined by tertiles of Gensini lesion severity score.

Results: The mean serum values for FGF 23 in the entire study population was 28.1 ± 17.3 RU/ml and for fetuin A was 473.1 ± 156.2 μg/ml. Patients with eGFR < 60 ml/min per 1.73 m(2) had significantly higher values of FGF 23 compared with patients with eGFR > 60 ml/min per 1.73 m(2). The Gensini score values significantly correlated with gender; arterial hypertension; and HDL cholesterol, eGFR, iPTH, FGF 23, and fetuin A levels. After the adjustments for traditional and uremia-related cardiovascular risk factors, the FGF 23 and fetuin A remained significant predictors of the Gensini score.

Conclusions: This study suggests that in a relatively young population with mild-to-moderate alteration of kidney function and with less traditional cardiovascular risk factors, anomalies of the serum FGF 23 and fetuin A levels appear early in the course of disease and are independent major predictors for extent of CAD.

MeSH terms

  • Adult
  • Biomarkers / blood
  • Blood Proteins / analysis*
  • Calcium / blood
  • Chi-Square Distribution
  • Chronic Disease
  • Coronary Angiography
  • Coronary Stenosis / blood
  • Coronary Stenosis / diagnostic imaging
  • Coronary Stenosis / etiology*
  • Cross-Sectional Studies
  • Female
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors / blood*
  • Glomerular Filtration Rate
  • Humans
  • Kidney Diseases / blood*
  • Kidney Diseases / complications
  • Kidney Diseases / physiopathology
  • Male
  • Middle Aged
  • Parathyroid Hormone / blood
  • Phosphorus / blood
  • Predictive Value of Tests
  • Prognosis
  • Regression Analysis
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index
  • Time Factors
  • Turkey
  • Vitamin D / blood
  • alpha-2-HS-Glycoprotein

Substances

  • AHSG protein, human
  • Biomarkers
  • Blood Proteins
  • FGF23 protein, human
  • PTH protein, human
  • Parathyroid Hormone
  • alpha-2-HS-Glycoprotein
  • Vitamin D
  • Phosphorus
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Calcium